Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups:

• Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus
• Control group: Patients will receive a treatment with corticoid ointment, with endoanal application

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment.

Patients with hemorrohoids grade II and III were included.

Patients were randomized into 2 groups:

• Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus. 1 ovule must be inserted daily during 14 days.
• Control group: Patients will receive a treatment with prednisolone ointment, with endoanal application 3 times per day during 14 days.

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment. Quantification of pain will be performed following a visual analogic scale ranging from 0 (absence of symptoms) to 100 (unbearable symptoms).

Inclusion Criteria:

• Grade II and III hemorrhoids

Exclusion Criteria:

• Grade I or IV hemorrhoids
• Patients with previous anal surgeries
• Patients having received previous pharmacological treatments for hemorrhoids

Symptoms will be assessed by a nurse blinded to the prescribed treatment